IV Cocaine Abuse: A Laboratory Model - 3

Cocaine-Related Disorders Clinical Trial

Official title:

IV Cocaine Abuse: A Laboratory Model

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00000214
• Other study ID #: NIDA-06234-3
• Secondary ID: R01DA006234R01-0
• Status: Completed
• Phase: Phase 2
• First received: September 20, 1999
• Last updated: August 27, 2015
• Start date: January 1992
• Est. completion date: January 1993

Study information

• Verified date: December 2012
• Source: New York State Psychiatric Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effects of buprenorpine on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: January 1993
• Est. primary completion date: January 1993
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 45 Years
• Eligibility: Please contact site for information.

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

• Cocaine-Related Disorders

Intervention

Drug:
• Buprenorphine

Locations

Country	Name	City	State
United States	Columbia University	New York	New York

Sponsors (3)

Lead Sponsor	Collaborator
New York State Psychiatric Institute	Columbia University, National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Foltin RW, Fischman MW. Effects of buprenorphine on the self-administration of cocaine by humans. Behav Pharmacol. 1994 Feb;5(1):79-89. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Direct cocaine effects (caridio, subjective)
Primary	Interaction of coc/bup on cardio measures
Primary	Ineraction of coc/bup on coc's subjective effects
Primary	Effects of buprenorphine on cocaine craving